Menu
 

Search abstracts


Second campaign to promote the colon cancer screening programme through swiss community pharmacies

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: BESANCON, Luc (pharmaSuisse, Innovation and International)
  • Co-author(s): Daniela Stebler: Innovation and International, pharmaSuisse, Bern-Liebefeld, Switzerland
    Andrea Brügger: Innovation and International, pharmaSuisse, Bern-Liebefeld, Switzerland
    Martine Ruggli: Innovation and International, pharmaSuisse, Bern-Liebefeld, Switzerland
    Luc Besançon: Innovation and International, pharmaSuisse, Bern-Liebefeld, Switzerland
    Fabian Vaucher: pharmaSuisse, Bern-Liebefeld, Switzerland
  • Abstract:

    Background

    In Switzerland, 4300 new patients are diagnosed every year with colon cancer, leading to 1700 deaths. Early detection is therefore key.

    Methods

    pharmaSuisse has developed a service integrating stool test for early detection of colon cancer. Patients are first screened. If no red flags are detected, they receive the stool test as well as

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses